<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60540">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02100735</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00016830</org_study_id>
    <nct_id>NCT02100735</nct_id>
  </id_info>
  <brief_title>Evaluation of an Analgosedation Protocol in Mechanically Ventilated Patients</brief_title>
  <official_title>Evaluation of an Analgosedation Protocol in Mechanically Ventilated Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampa General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampa General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how the investigators provide sedation (medicine
      that make you sleepy) in the investigators intensive care unit (ICU). This study will look
      at a new way of using sedation in the ICU to see what effect it has on patients and if it
      decreases the amount of time spent on mechanical ventilation (machine that breathes for
      you), and in the ICU.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Days on mechanical ventilation</measure>
    <time_frame>Participants will be assessed daily for the duration of their stay in the ICU, an expected average of 4-5 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU Length of stay</measure>
    <time_frame>Participants will be followed for the entire length of their ICU stay, expected average of 4-7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 day mortality</measure>
    <time_frame>Participants will be followed for 28 days from enrollment into the study</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Effect of Protocolized Sedation on Days of Mechanical Ventilation in the ICU</condition>
  <arm_group>
    <arm_group_label>Sedation protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation protocol is a document that will be used to guide the adjustment of sedation in the ICU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Current practices</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sedation protocol</intervention_name>
    <arm_group_label>Sedation protocol</arm_group_label>
    <arm_group_label>Standard of care</arm_group_label>
    <other_name>The sedation protocol is a document that wil lbe used by healthcare providers to guide sedation used in the ICU</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years of age and older

          -  Patients expected to require mechanical ventilation for greater than 48 hrs

        Exclusion Criteria:

          -  Need for continuous neuromuscular blockade

          -  Severe chronic neurocognitive dysfunction

          -  Tracheostomy at the time of study enrollment

          -  Alcohol withdrawal risk or symptoms

          -  Drug overdose

          -  Chronic use of narcotics

          -  Active seizures
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Beatrice Adams, PharmD</last_name>
    <email>badams@tgh.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Beatrice Adams, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maresa Glass, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brice Taylor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 27, 2014</lastchanged_date>
  <firstreceived_date>March 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampa General Hospital</investigator_affiliation>
    <investigator_full_name>Beatrice Adams</investigator_full_name>
    <investigator_title>PGY2 Critical Care Pharmacy Resident</investigator_title>
  </responsible_party>
  <keyword>sedatives</keyword>
  <keyword>analgesics</keyword>
  <keyword>protocol</keyword>
  <keyword>mechanical ventilation</keyword>
  <keyword>analgosedation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
